Mohamed Nabil was born in Makka, Saudi Arabia, in 1979. He received his master’s and Ph.D. in pharmacology and toxicology in 2014 and 2020 from Zagazig University. From 2015 to 2020, he worked at a research center concerned with the preclinical studies and development of pharmaceutical industries where he acts in the last three years as a manager of the molecular biology department. Since 2020 he is a lecturer of clinical pharmacology and bioassay at Deraya University. He is the lead author of 3 publications and co-author of another 3 publications. His research activity is focused on gastritis, stroke, metabolic syndrome, and neurodegenerative disorders. His studies main to biologically evaluate natural products, finding new indications of commercially used drugs, and improvement of neuroregeneration after neuro damage.